Longevity & Healthspan

Longevity & Healthspan

ArentFox Schiff is the destination law firm for companies operating at the intersection of longevity, healthspan, and anti-aging innovation.

This burgeoning ecosystem of health care, life sciences, wellness, and technology companies incorporates:

  • Biotech and therapeutics focused on the biology of aging.
  • Wearable health tech and digital health platforms.
  • Precision diagnostics and personalized medicine.
  • Consumer products and services for performance, recovery, and wellness.

Businesses building in this cross-sector space require counsel that understands complex, intersecting regulatory regimes and can execute sophisticated intellectual property, transactional, privacy, and consumer protection strategies.

That’s where we come in.

How ArentFox Schiff Helps Longevity Companies Succeed

ArentFox Schiff is the go-to counsel for companies shaping the future of how health is measured, delivered, and optimized.

Our Longevity & Healthspan Industry Group draws on the firm’s premier Health Care, FDA, Privacy & Data Security, Patent, Corporate, and Government Relations capabilities. Our multidisciplinary team of attorneys provides practical, forward-looking counsel that reflects a deep understanding of the regulatory, commercial, and scientific dynamics shaping this flourishing field, with core competencies in:

  • Regulatory strategy and compliance, including FDA and FTC oversight, human subjects research, corporate practice of medicine laws, telehealth, health care and senior living facility licensing and regulation, and advertising and product labeling.
  • Value-based care and innovative reimbursement models, including shared savings arrangements, risk-based contracting, alternative payment models, provider alignment strategies, and regulatory considerations associated with outcomes-focused care delivery.
  • Data privacy, security, and governance, including compliance with HIPAA, the FTC Act, and state consumer privacy laws, as well as health information exchange, interoperability frameworks, and the use of AI.
  • Intellectual property protection and commercialization, including patents, trade secrets, licensing, and technology transfer for therapeutics, diagnostics, devices, software, and associated technologies.
  • Corporate and transactional matters, including company formation, venture financing, strategic collaborations, joint ventures, public and private securities offerings, and mergers and acquisitions.
  • Government relations, supporting companies navigating evolving federal and state policymaking processes, regulatory rulemakings, and public funding opportunities.

Who We Serve

We deliver cross-practice counsel across the longevity value chain, including:

  • Biotechnology and life sciences companies, including those developing therapeutics, diagnostics, and medical devices targeting aging biology, metabolic health, neurodegeneration, and regenerative medicine.
  • Precision diagnostics and direct-to-consumer testing companies, including genomics, epigenetics, metabolomics, microbiome analysis, and longitudinal biomarker assessment services.
  • Freestanding imaging centers, including preventive and whole-body imaging providers.
  • Wearable and consumer health technology companies, including sensor-based devices and smart health technologies that track physiological signals, performance, recovery, and other metrics.
  • Digital health and AI-powered platforms, including software and analytics businesses offering personalized health insights, clinical decision support, and coaching tools.
  • Longevity clinics and preventive care practices, including concierge medicine practices, functional and integrative medicine practices, and telehealth providers delivering personalized, proactive care.
  • Nutrition, supplementation, and cosmetic companies, including businesses focused on food-as-medicine approaches, nutraceuticals, peptides, topical and cosmetic products, and science-backed consumer wellness formulations.
  • Fitness, recovery, and performance brands, including companies offering structured training methodologies, recovery and regeneration services, performance optimization technologies, and data-informed physical conditioning programs.
  • Health care distributors and logistics providers, including third-party logistics and direct-to-patient operators, that work with longevity companies to deliver cold-chain services, at-home test kits and devices, and integrated fulfillment solutions essential for growth.
  • Medical travel and wellness tourism companies, including longevity-focused hospitality brands, destination health clinics, and international providers offering integrated preventive, diagnostic, and regenerative health experiences.
  • Long-term care and senior living owners and operators, including independent living, assisted living, memory care, skilled nursing, and continuing care retirement communities, as they integrate longevity-driven wellness, diagnostics, and technology-enabled services into community operations.
  • Longevity-focused investors, including venture capital, private equity, family offices, and strategic investors active across the health, wellness, and life sciences sectors.

While many firms touch aspects of the longevity market, ArentFox Schiff is the leading firm with a dedicated, integrated practice to support these companies across their full lifecycle — from formation and product development through commercialization, scaling, and exit.